← Leaderboards
Xiaoyang Qi
Children'S Hospital Med Ctr (Cincinnati)
$7,187,712
Attributed
$11,591,789
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,591,789 · 8
By mechanism
R44$4,368,595 · 1
R01$3,613,149 · 3
T32$2,085,874 · 1
R61$803,958 · 1
R21$447,075 · 1
R43$273,138 · 1
Top collaborators
- Kevin Xu6 shared
- Vladimir Bogdanov4 shared
- Ying Sun3 shared
- Pier P Scaglioni1 shared
Most similar at Children'S Hospital Med Ctr (Cincinnati)
Same institution · by research overlap
- Gregory A. Grabowski$10,832,896
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsBeta-Glucosidase Stimulating ProteinPhosphatidylserinesAnimalsCellsInnovationAnimal ModelMediatingPharmaceutical PreparationsPropertyGlucosylceramidesNanovesicleDiagnosisDrug KineticsAffinityNormal CellCell SurfacePhospholipidsKillingsLysosomal ProteinsChemotherapyGliomaCancer CellNeoplastic Cell
Grant awards (25)
SapC-based Brain-targeting Delivery of Long-acting Enzymes for Neuronopathic Gaucher Disease Therapy$803,958
R61 · FY2025 · NS
Systemic Enzyme Delivery by a Brain Targeted SapC-DOPS Nanocarrier for Treatment of Neuronopathic Gaucher Disease$623,281
R01 · FY2025 · NS
Systemic Enzyme Delivery by a Brain Targeted SapC-DOPS Nanocarrier for Treatment of Neuronopathic Gaucher Disease$653,309
R01 · FY2024 · NS
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program$438,062
T32 · FY2023 · CA
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program$489,120
T32 · FY2022 · CA
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program$461,928
T32 · FY2021 · CA
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program$400,597
T32 · FY2020 · CA
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program$296,167
T32 · FY2019 · CA
Intravenous Enzyme Replacement Therapy for CNS Disorders$196,625
R21 · FY2016 · NS · contact PI
SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme$948,501
R44 · FY2015 · CA
Acidic Phospholipid-Selective Treatment for Neuroblastoma$325,282
R01 · FY2015 · CA · contact PI
Intravenous Enzyme Replacement Therapy for CNS Disorders$250,450
R21 · FY2015 · NS · contact PI
SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme$948,501
R44 · FY2014 · CA
Acidic Phospholipid-Selective Treatment for Neuroblastoma$315,542
R01 · FY2014 · CA · contact PI
SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme$960,270
R44 · FY2013 · CA
Acidic Phospholipid-Selective Treatment for Neuroblastoma$305,799
R01 · FY2013 · CA · contact PI
Acidic Phospholipid-Selective Treatment for Neuroblastoma$330,349
R01 · FY2012 · CA · contact PI
SapC-DOPS nanovesicles for Treating Glioblastoma Multiforme$840,956
R44 · FY2011 · CA
Acidic Phospholipid-Selective Treatment for Neuroblastoma$334,587
R01 · FY2011 · CA · contact PI
SapC-DOPS nanovesicles for Treating Glioblastoma Multiforme$670,367
R44 · FY2010 · CA
SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme$273,138
R43 · FY2008 · CA
STUDY OF SAPOSINS'BIOLOGICAL FUNCTIONS$181,250
R01 · FY2003 · DK
STUDY OF SAPOSINS'BIOLOGICAL FUNCTIONS$181,250
R01 · FY2002 · DK
STUDY OF SAPOSINS'BIOLOGICAL FUNCTIONS$181,250
R01 · FY2001 · DK
STUDY OF SAPOSINS'BIOLOGICAL FUNCTIONS$181,250
R01 · FY2000 · DK